Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2010
06/01/2010US7728027 reacting 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone with 1-(tert-butoxycarbonyl)-L-proline, then treating the product with ammonium acetate and deprotection to form chemical intermediates for viricides; cost efficiency; industrial scale
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2400626C Estrogen receptor modulators
05/2010
05/27/2010WO2010059393A1 Serotonin receptor modulators
05/27/2010WO2010059390A1 Modulators of serotonin receptor
05/27/2010WO2010058353A1 Novel bis-amides as antimalarial agents
05/27/2010WO2010057899A1 Cycloalkyl amino carbonyl derivatives as bradykinin-b1 receptor antagonists
05/27/2010WO2009153178A3 Aryl ketone as mri
05/27/2010WO2009129387A3 Cationic lipids and uses thereof
05/27/2010US20100130739 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
05/27/2010US20100130737 Regulating Agent of GPR34 Receptor Function
05/27/2010US20100130736 Methods of creating an index
05/27/2010US20100130523 Mono-hydrochloric salts of an inhibitor of histone deacetylase
05/27/2010US20100130507 Prostaglandin derivatives
05/27/2010US20100130501 Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
05/27/2010US20100130495 Compounds 563
05/27/2010US20100130471 Renin Inhibitors
05/27/2010US20100127215 Novel organometallic complexes which emit in the red to green spectral region and their use in oleds
05/27/2010CA2742903A1 Novel bis-amides as antimalarial agents
05/26/2010EP2189446A1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy]-n'-(butoxycarbonyl)benzamidine crystals
05/26/2010EP2188275A2 Novel preparation process
05/26/2010EP1867634B1 Ligand for vesicular acetylcholine transporter
05/26/2010EP1730103B1 Formamide derivatives useful as adrenoceptor
05/26/2010CN1953963B Process for producing cyclic N-hydroxyimide compound
05/26/2010CN1867331B Thalidomide analogs as TNF-alpha modulators
05/26/2010CN1826115B Substituted piperidine compounds and methods of their use
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN1359390B Factor VII a inhibitors
05/26/2010CN101712772A Light stabilizer and production method thereof
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/26/2010CN101712646A Alkoxyamines containing a radically polymerizable group
05/26/2010CN101712645A Preparation method for (2R, 4R)-4-substituted-2-piperidine carboxylic acid compound and intermediate thereof
05/26/2010CN101712632A Substituted tetracycline compounds
05/26/2010CN101111477B Benzoyl-tetrahydropyridine as glyt-1 inhibitors
05/25/2010US7723522 Pyridine derivative production method
05/25/2010US7723358 such as hypertriglyceridaemia, hypercholesterolemia, dyslipidaemia, or obesity; 6-methyl-N-[3-[[1-(methylsulfonyl)-4-piperidinyl]oxy]phenyl]-4'-(trifluoro-methoxy) [1,1'-biphenyl]-2-carboxamide
05/25/2010US7723333 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome
05/25/2010US7723324 Treating anxiety and insomnia; drugs facilitate the inhibitory action of the neurotransmitter GABA; 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-1-thiophen-2-yl-ethanone for example
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/20/2010WO2010056941A1 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/20/2010WO2010056939A1 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
05/20/2010WO2010056938A1 Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/20/2010WO2010055887A1 Novel sulfonium salt, method for producing same and use of same
05/20/2010WO2010014933A3 Psma-binding agents and uses thereof
05/20/2010US20100125141 Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/20/2010US20100125093 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
05/20/2010US20100125092 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/20/2010US20100125079 Biphenyl compounds useful as muscarinic receptor antagonists
05/20/2010US20100125076 Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
05/20/2010US20100125075 Antibacterial Agents
05/20/2010US20100125058 Naphthylacetic acids
05/20/2010CA2742114A1 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
05/20/2010CA2742105A1 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/20/2010CA2739992A1 Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2185558A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
05/19/2010EP2185514A1 Vinyl-aryl derivatives for inflammation and immune-related uses
05/19/2010EP2185151A1 Anti-inflammatory composition
05/19/2010EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same
05/19/2010CN101711236A n-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/18/2010US7718674 Nerve membrane stabiizers; inducing local, topical or dermal anesthesia
05/18/2010US7718673 Heterocyclic amides such as beta-(((1-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)-1-oxobutyl)-4 -piperidinyl)carbonyl)amino) -,(beta 3S)-3-quinolinepropanoic acid, used as antagonists for cellular adhesion molecules
05/18/2010US7718671 Substituted small-molecule arylthiourea compounds are potent and/or selective inhibitors of viral replication in vivo, particularly Hepatitis C virus replication; e.g., 1-(3-benzyloxy)phenylthiourea; side effect reduction
05/18/2010US7718656 Nitrooxyderivatives of prostaglandin amides, e.g., N-(3-(nitrooxy)propyl) 1R-[1 alpha (Z),2 beta (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenamide; reduced side effects,wider pharmacological activity, enhanced tolerability, long-acting hypotensive activity
05/14/2010WO2010053944A1 Improved method of making piperidine derivatives
05/14/2010WO2010053583A2 Small molecule cd4 mimetics and uses thereof
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010017343A3 Flupirtine hydrochloride maleic acid cocrystal
05/14/2010WO2010017135A3 Novel forms of eperisone
05/14/2010CA2742741A1 Substituted disulfonamides
05/13/2010US20100120861 Benzoic acid inhibitors of atp-sensitive potassium channels
05/13/2010US20100120859 Novel case of renin inhibitors
05/13/2010US20100120858 Piperidine Derivatives
05/13/2010US20100120845 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
05/13/2010US20100120813 Peripheral opioid receptor antagonists and uses thereof
05/13/2010US20100120615 4-cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides
05/12/2010EP2183219A2 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/12/2010EP2183218A2 Novel b1 antagonists
05/12/2010EP2183217A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
05/12/2010EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors
05/12/2010CN101704924A Method for producing crosslinked poly (meth) acrylate compound
05/12/2010CN101704779A Preparation method for feed additive dihydropyridine
05/12/2010CN101190915B Anti-thrombus N-butyl-2,2-dimethyl-4-oxy-tetrahydroimidazopyridoindole and its synthesis and application
05/12/2010CN101100453B Method for synthesizing ifenprodil tartrate
05/12/2010CN101041660B 1,2-dihydrogen pyridine derivative, carbon glycosides intermediate and preparation method and application thereof
05/11/2010US7714138 Monocyclic heterocycles as kinase inhibitors
05/11/2010US7714012 Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
05/11/2010US7713998 Nitrogenous heterocyclic compound and pharmaceutical use thereof
05/11/2010US7713995 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
05/11/2010US7713979 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
05/11/2010US7713957 Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist
05/11/2010CA2462110C Phenyl-piperazine derivatives as serotonin reuptake inhibitors
05/06/2010WO2010051447A1 Sulfonamide containing compounds and uses thereof
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050436A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010WO2010049946A2 Thyroid receptor ligands
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 380